Revolab provides an at-home finger-prick blood test kit and a companion app that returns lab results within 24 hours. Its platform currently supports more than 30 different blood tests, including CBC, glucose, thyroid panels, STD tests, and enzyme markers, plus tailored panels for vegans and vegetarians. The company achieved CE certification for its products, enabling sales across Europe, and reports €100K of pre-orders. Revolab says the pandemic accelerated demand for self-testing, particularly among people with chronic conditions. The founders are Ovidijus Kalinas and Jekaterina Kaliniene; Jekaterina previously served as CEO of Synlab Lithuania. The company is pursuing product development and expansion into EU and US markets.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2021